Kobo Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 11, 2026	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	69	91	45	131	176	69
Market Cap Growth	1.40%	100.00%	-65.45%	-25.68%	156.06%	-37.17%
Enterprise Value	1,464	1,486	1,449	2,007	2,868	2,608
Last Close Price	2.89	3.80	1.90	5.50	7.40	2.89
PB Ratio	-0.05	-0.07	-0.04	-0.11	-0.16	-0.08
P/FCF Ratio	-	44.47	5.18	0.14	7.03	0.48
P/OCF Ratio	-	44.47	5.18	0.14	7.03	0.48
EV/FCF Ratio	-	729.95	165.63	2.14	114.31	18.02
Debt / Equity Ratio	-1.05	-1.05	-1.09	-1.15	-2.43	-2.85
Debt / FCF Ratio	-	686.11	159.89	1.50	103.83	17.33
Net Debt / Equity Ratio	-1.05	-1.05	-1.09	-1.15	-2.42	-2.85
Net Debt / EBITDA Ratio	-141.88	-159.90	-146.48	-10.45	-117.39	-96.11
Net Debt / FCF Ratio	-	685.22	159.75	1.50	103.21	17.32
Inventory Turnover	-	-	-	0.99	-	-
Quick Ratio	-	0.07	0.07	0.07	0.32	0.33
Current Ratio	-	0.23	0.23	0.23	0.53	0.56
Return on Assets (ROA)	-	-4.21%	-4.06%	-7.22%	-2.10%	-2.23%
Return on Capital Employed (ROCE)	-	5.10%	5.50%	21.30%	11.40%	17.70%
Earnings Yield	-73.09%	-54.44%	-122.68%	-116.20%	-109.08%	-305.08%
FCF Yield	-	2.25%	19.32%	715.50%	14.23%	210.20%
Buyback Yield / Dilution	0.80%	0.06%	-	-	-0.04%	0.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.